Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

NCT01198925 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01198925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01198925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
September 23, 2010
Completion date
May 3, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious disease